Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Harbor Health Care |
| Investment focus | Aktien, Welt, Gesundheitswesen |
| Fund size | EUR 13 m |
| Total expense ratio | 0,89% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Actively managed |
| Sustainability | Nein |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 19,61% |
| Inception/ Listing Date | 4. April 2019 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Irland |
| Fund Provider | HANetf |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | J.P. Morgan Administration Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | J.P. Morgan SE - Dublin Branch |
| Revision Company | Ernst and Young |
| Fiscal Year End | 1. März |
| Swiss representative | Waystone |
| Swiss paying agent | Helvitsche Bank |
| Germany | 30% Teilfreistellung |
| Switzerland | ESTV Reporting |
| Austria | Meldefonds |
| UK | UK Reporting |
| Italy | 26,0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Eli Lilly & Co. | 9,34% |
| Ascendis Pharma A/S | 8,76% |
| Legend Biotech | 5,85% |
| Abivax | 5,08% |
| Rhythm Pharmaceuticals | 4,68% |
| Intuitive Surgical | 4,33% |
| Insmed | 4,26% |
| Natera | 4,14% |
| AbbVie, Inc. | 4,10% |
| Revolution Medicines | 3,91% |
| USA | 79,31% |
| Sonstige | 20,69% |
| Gesundheitswesen | 80,34% |
| Sonstige | 19,66% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0,00 € | 0,00 € | Zum Angebot** | |
| | 0,00 € | 0,00 € | Zum Angebot* | |
| | 0,00 € | 0,00 € | Zum Angebot* | |
| | 0,00 € | 0,00 € | Zum Angebot* | |
| | 0,00 € | 0,00 € | Zum Angebot* |
| Broker | Rating | Ordergebühr | ETF-Sparpläne | |
|---|---|---|---|---|
| | 0,99 € | 3552 | Zum Angebot** | |
| | 0,00 € | 2606 | Zum Angebot* | |
| | 0,95 € | 2533 | Zum Angebot* | |
| | 1,00 € | 2624 | Zum Angebot* | |
| | 0,00 € | 1868 | Zum Angebot* |
| YTD | +2.80% |
| 1 month | -7.19% |
| 3 months | +7.40% |
| 6 months | +8.74% |
| 1 year | +12.78% |
| 3 years | +1.75% |
| 5 years | -29.88% |
| Since inception (MAX) | +0.58% |
| 2025 | +5.94% |
| 2024 | -3.47% |
| 2023 | -1.92% |
| 2022 | -25.63% |
| Volatility 1 year | 19.61% |
| Volatility 3 years | 20.33% |
| Volatility 5 years | 22.93% |
| Return per risk 1 year | 0.65 |
| Return per risk 3 years | 0.03 |
| Return per risk 5 years | -0.30 |
| Maximum drawdown 1 year | -17.56% |
| Maximum drawdown 3 years | -22.24% |
| Maximum drawdown 5 years | -46.71% |
| Maximum drawdown since inception | -46.71% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | W311 | - - | - - | - |
| Borsa Italiana | EUR | WELL | WELL IM WELLEUIV | WELL.MI WELLEURINAV=SOLA | RBC Europe Ltd |
| Euronext Paris | EUR | WELL | WELL FP WELLEUIV | WELP.PA WELLEURINAV=SOLA | RBC Europe Ltd |
| London Stock Exchange | GBX | WELP | WELP LN | WELP.L | RBC Europe Ltd |
| London Stock Exchange | USD | WELL | WELL LN | HAWELL.L | RBC Europe Ltd |
| London Stock Exchange | GBP | - | RBC Europe Ltd | ||
| SIX Swiss Exchange | CHF | WELL | WELL SW WELLEUIV | WELL.S WELLEURINAV=SOLA | RBC Europe Ltd |
| XETRA | EUR | W311 | W311 GY WELLEUIV | W311.DE WELLEURINAV=SOLA | RBC Europe Ltd |
| Fondsname | Fondsgröße in Mio. € (AuM) | TER p.a. | Ausschüttung | Replikation |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 1.045 | 0,40% p.a. | Thesaurierend | Sampling |
| L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 250 | 0,49% p.a. | Thesaurierend | Vollständig |
| L&G Pharma Breakthrough UCITS ETF | 19 | 0,49% p.a. | Thesaurierend | Vollständig |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 12 | 0,35% p.a. | Thesaurierend | Vollständig |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 9 | 0,25% p.a. | Thesaurierend | Vollständig |